Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M16.6Revenue (TTM) $M0.9Net Margin (%)-2,718.1Altman Z-Score-16.9
Enterprise Value $M-1.2EPS (TTM) $-2.4Operating Margin %-3,006.1Piotroski F-Score3
P/E(ttm)--Beneish M-Score-2.6Pre-tax Margin (%)-2,718.1Higher ROA y-yY
Price/Book2.310-y EBITDA Growth Rate %-29.7Quick Ratio5.6Cash flow > EarningsN
Price/Sales12.05-y EBITDA Growth Rate %-52.4Current Ratio5.6Lower Leverage y-yY
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-73.6Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)-315.9Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M14.3ROIC % (ttm)--Gross Margin Increase y-yN

Gurus Latest Trades with AEZS

Number of guru portfolios checked: 68.
Ticker Guru Date Action
Impact Price Range
(Average)*
Current Price Change from Average Comment Current Shares

AEZS is held by these investors:



AEZS: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Ernst, JürgenDirector 2014-11-12Buy600$60-98.03view
Ernst, JürgenDirector 2014-11-12Buy394$61.79-98.09view
Ernst, JürgenDirector 2014-11-12Buy76$61.49-98.08view
Ernst, JürgenDirector 2014-11-12Buy31$61.4-98.08view
Ernst, JürgenDirector 2014-11-12Buy149$61.46-98.08view
Dodd, David AlanDirector, Senior Officer 2014-11-10Buy85$56.5-97.91view
Dodd, David AlanDirector, Senior Officer 2014-11-10Buy10$56.97-97.93view
Dodd, David AlanDirector, Senior Officer 2014-11-10Buy344$57-97.93view
Dodd, David AlanDirector, Senior Officer 2014-11-10Buy30$57.5-97.95view
Dodd, David AlanDirector, Senior Officer 2014-11-10Buy1,281$58-97.97view

Quarterly/Annual Reports about AEZS:

    News about AEZS:

    Articles On GuruFocus.com
    Billionaires Hold Waning Biotechs 42% Off Oct 16 2013 
    Can Keryx Succeed Without Partnership? Apr 24 2012 
    Keryx Still Has High Potential from Zerenex Apr 12 2012 
    Opportunistic Coat-tailing Jan 05 2010 

    More From Other Websites
    Is the Options Market Predicting a Spike in Aeterna Zentaris (AEZS) Stock? May 22 2017
    Aeterna Zentaris Announces Election of Directors at 2017 Shareholders' Meeting May 09 2017
    Aeterna Zentaris reports 1Q loss May 08 2017
    Aeterna Zentaris Reports First Quarter 2017 Financial and Operating Results May 08 2017
    Aeterna Zentaris to Announce First Quarter 2017 Financial and Operating Results on May 8, 2017 May 02 2017
    Today's Research Reports on Stocks to Watch: AEterna Zentaris and Exelixis May 02 2017
    AEterna's stock plunges toward record low after cancer treatment fails in Phase 3 trial May 01 2017
    Aeterna Zentaris Announces that ZoptEC Phase 3 Clinical Study of Zoptrex™ Did Not Achieve its... May 01 2017
    Aeterna Zentaris to Announce Top-Line Results of the ZoptEC Phase 3 Clinical Study of Zoptrex™ Apr 28 2017
    Aeterna Zentaris Announces Replacement At the Market Issuance Program Apr 27 2017
    Aeterna Zentaris Mails Management Information Circular in Connection with Annual Meeting of... Apr 03 2017
    Aeterna Zentaris shares surge almost 14% premarket on news of NDA for growth hormone drug Mar 30 2017
    Aeterna Zentaris Intends to File NDA with Respect to Macrilen™ in Third Quarter of 2017 Mar 30 2017
    Aeterna Zentaris Announces At the Market Issuance Program Mar 28 2017
    Æterna Zentaris, Inc. :AEZS-US: Earnings Analysis: Q4, 2016 By the Numbers : March 27, 2017 Mar 27 2017
    Aeterna Zentaris Reports Fourth Quarter and Full-Year 2016 Financial and Operating Results Mar 15 2017
    Aeterna Zentaris Announces EMA Pediatric Committee Agreement on the Pediatric Investigation Plan for... Mar 07 2017
    Aeterna Zentaris to Announce Fourth Quarter and Full-Year 2016 Financial and Operating Results on... Mar 06 2017
    Aeterna Zentaris Announces Presentation Regarding Macrilen™ at 99th Annual Meeting of the... Mar 02 2017

    Add Notes, Comments

    If you want to ask a question or report a bug, please create a support ticket.
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)